Xylitol Toxicosis

Issues

Xylitol Toxicosis

Xylitol – a 5-carbon sugar alcohol used as a sweetener; present in some sugar-free gums, candies, toothpastes, mouthwashes, vitamins, liquid medications, and baked goods. It is also available as a granulated powder for cooking and baking.

Ingestion by dogs can cause vomiting, weakness, ataxia, seizures, hypokalemia, hypophosphatemia/hyperphosphatemia, and hypoglycemia due to excess insulin release.

Mild to moderate elevations of ALT can be seen within 4 hours of ingestion.

Hepatic failure with high liver enzymes, hyperbilirubinemia, and coagulopathy may occur at dosages > 0.5 g/kg.

Dosages of > 0.075–0.1 g/kg of xylitol may cause hypoglycemia.

 

SIGNALMENT

Dogs—no breed, age, or sex predilection

Cats—toxicity not established

 

SIGNS

May develop within 15–30 minutes of exposure; with sugar-free gums, hypoglycemia may be delayed up to 12 hours.

Vomiting common.

Progressive lethargy, weakness, ataxia, collapse, and seizures.

Hepatic failure may be accompanied by vomiting and widespread hemorrhage including petechiae, ecchymosis, and gastrointestinal and abdominal bleeding.

Clinical signs of hypoglycemia may not be evident prior to onset of hepatic failure.

 

CAUSES & RISK FACTORS

Ingestion of xylitol or xylitol-containing products

 

DIAGNOSIS

DIFFERENTIAL DIAGNOSIS

Hypoglycemia

Insulin overdose

Sulfonylurea antihyperglycemic agents

Insulinoma (pancreatic β-cell tumor)

Acute Hepatic Failure

Acetaminophen

Aflatoxin

Blue-green algae

Amanita and similar hepatotoxic mushrooms

Iron

Sago palms (Cycad spp.)

Leptospirosis

 

CBC/BIOCHEMISTRY/URINALYSIS

Hypoglycemia

Hypokalemia

Hypophosphatemia or hyperphosphatemia

Increased ALT, AST, SAP—may be delayed up to 24–48 hours

Bilirubinemia

Thrombocytopenia

 

OTHER LABORATORY TESTS

Prolonged PT/PTT

Increased FDP, D-dimers and/or decreased fibrinogen

 

PATHOLOGIC FINDINGS

Severe hepatic necrosis

Widespread hemorrhage

 

TREATMENT

Decontamination—emesis if patient is asymptomatic; activated charcoal not likely to be beneficial.

Monitor at 1–2-hour intervals for hypoglycemia and hypokalemia and correct as needed.

Monitor for hepatic changes.

 

MEDICATIONS

DRUG(S)

Dextrose—0.5–1 g/kg IV followed by a 2.5–5% CRI—consider starting with dosages of > 0.1 g/kg.

Potassium chloride—supplement in fluids if potassium value < 2.5 mmol/L.

 

FOLLOW-UP

Monitor glucose levels for at least 24 hours.

Monitor hepatic enzymes, bilirubin, PT/PTT, and platelets for at least 72 hours.

Prognosis good for uncomplicated hypoglycemia with mild-to-moderate elevations of ALT; guarded to poor if severe hepatic necrosis occurs especially if hyperphosphatemia is present.

 

MISCELLANEOUS

ABBREVIATIONS

ALT = alanine aminotransferase

AST = aspartate aminotransferase

FDP = fibrin degradation products

PT = prothrombin time

PTT = partial thromboplastin time

Visit your veterinarian as early recognition, diagnosis, and treatment are essential.